Science Explorer Back to mapMap
Discussion
Company · Ahmedabad · India

Torrent Pharma (India)

torrentpharma.comROR OpenAlex
Research works
109
▲ 207% vs 2018-21
Citations
3k
27.4 per fractional work
Top-10% rate
4.7%
all institutions 10.0%
Open access
50%
world 40%
International
12%
world 18%
Torrent Pharma (India)

Not ranked overall: Torrent Pharma (India) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Torrent Pharma (India) work in?

In 2022-now, 55% of research at Torrent Pharma (India) is in Health Sciences, 22% in Life Sciences. Its largest fields are Medicine (53%), Biochemistry, Genetics and Molecular Biology (13%), Engineering (7%). It does 1.9× the world's share of Health Sciences.

Health Sciences: 15 fractional works · 55.4% of its workMedicine: 15 fractional works · 52.7% of its workPharmacology: 2 fractional works · 7.8% of its workEndocrinology, Diabetes and Metabolism: 2 fractional works · 7.1% of its workCardiology and Cardiovascular Medicine: 2 fractional works · 6.1% of its workOncology: 2 fractional works · 5.4% of its workNeurology: 1 fractional works · 3.6% of its workHematology: 1 fractional works · 3.5% of its workDermatology: 1 fractional works · 2.3% of its workPsychiatry and Mental health: 0 fractional works · 1.8% of its workPhysiology: 0 fractional works · 1.5% of its workReproductive Medicine: 0 fractional works · 1.4% of its workComplementary and alternative medicine: 0 fractional works · 1.3% of its workEpidemiology: 0 fractional works · 1.2% of its workPulmonary and Respiratory Medicine: 0 fractional works · 1.2% of its workUrology: 0 fractional works · 1.2% of its workRehabilitation: 0 fractional works · 1.0% of its workSurgery: 0 fractional works · 1.0% of its workImmunology and Allergy: 0 fractional works · 1.0% of its workPathology and Forensic Medicine: 0 fractional works · 0.9% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.8% of its workGenetics: 0 fractional works · 0.7% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.4% of its workGeriatrics and Gerontology: 0 fractional works · 0.4% of its workInfectious Diseases: 0 fractional works · 0.3% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.3% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.2% of its workRheumatology: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 1.5% of its workGeneral Health Professions: 0 fractional works · 1.2% of its workSpeech and Hearing: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workNursing: 0 fractional works · 1.1% of its workNutrition and Dietetics: 0 fractional works · 1.1% of its workLife Sciences: 6 fractional works · 22.4% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 12.9% of its workMolecular Biology: 2 fractional works · 6.9% of its workCancer Research: 1 fractional works · 3.3% of its workGenetics: 1 fractional works · 2.5% of its workEndocrinology: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 4.4% of its workPharmacology: 1 fractional works · 2.3% of its workPharmaceutical Science: 1 fractional works · 2.1% of its workNeuroscience: 1 fractional works · 3.1% of its workCellular and Molecular Neuroscience: 1 fractional works · 2.0% of its workNeurology: 0 fractional works · 0.4% of its workDevelopmental Neuroscience: 0 fractional works · 0.3% of its workCognitive Neuroscience: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 0 fractional works · 1.2% of its workFood Science: 0 fractional works · 0.8% of its workPlant Science: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workImmunology and Microbiology: 0 fractional works · 0.9% of its workImmunology: 0 fractional works · 0.9% of its workPhysical Sciences: 5 fractional works · 17.1% of its workEngineering: 2 fractional works · 6.9% of its workElectrical and Electronic Engineering: 1 fractional works · 3.8% of its workControl and Systems Engineering: 0 fractional works · 1.2% of its workAerospace Engineering: 0 fractional works · 0.8% of its workBiomedical Engineering: 0 fractional works · 0.8% of its workMechanical Engineering: 0 fractional works · 0.4% of its workChemistry: 1 fractional works · 2.9% of its workOrganic Chemistry: 0 fractional works · 1.4% of its workAnalytical Chemistry: 0 fractional works · 1.2% of its workSpectroscopy: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workComputer Science: 1 fractional works · 2.8% of its workArtificial Intelligence: 0 fractional works · 1.5% of its workComputational Theory and Mathematics: 0 fractional works · 0.7% of its workComputer Networks and Communications: 0 fractional works · 0.3% of its workSignal Processing: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEnergy: 1 fractional works · 2.0% of its workRenewable Energy, Sustainability and the Environment: 1 fractional works · 2.0% of its workEnvironmental Science: 0 fractional works · 0.9% of its workGlobal and Planetary Change: 0 fractional works · 0.4% of its workEnvironmental Chemistry: 0 fractional works · 0.3% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.3% of its workMaterials Science: 0 fractional works · 0.8% of its workElectronic, Optical and Magnetic Materials: 0 fractional works · 0.4% of its workMaterials Chemistry: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysics and Astronomy: 0 fractional works · 0.4% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 0.4% of its workMathematics: 0 fractional works · 0.3% of its workStatistics and Probability: 0 fractional works · 0.3% of its workSocial Sciences: 1 fractional works · 5.1% of its workEconomics, Econometrics and Finance: 1 fractional works · 1.8% of its workEconomics and Econometrics: 1 fractional works · 1.8% of its workPsychology: 0 fractional works · 1.5% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.9% of its workApplied Psychology: 0 fractional works · 0.6% of its workSocial Sciences: 0 fractional works · 1.2% of its workEducation: 0 fractional works · 0.6% of its workSociology and Political Science: 0 fractional works · 0.6% of its workBusiness, Management and Accounting: 0 fractional works · 0.3% of its workManagement Information Systems: 0 fractional works · 0.3% of its workDecision Sciences: 0 fractional works · 0.3% of its workManagement Science and Operations Research: 0 fractional works · 0.3% of its workALL ITS WORKTorrent Pharma(India)28fractional works, 2022-now
Life Sciences22%Physical Sciences17%Health Sciences55%Social Sciences5%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 21 fields, with their numbers
    1. Medicine1552.7%
    2. Health Professions01.5%
    3. Nursing01.1%
    1. Biochemistry, Genetics and Molecular Biology412.9%
    2. Pharmacology, Toxicology and Pharmaceutics14.4%
    3. Neuroscience13.1%
    4. Agricultural and Biological Sciences01.2%
    5. Immunology and Microbiology00.9%
    1. Engineering26.9%
    2. Chemistry12.9%
    3. Computer Science12.8%
    4. Energy12.0%
    5. Environmental Science00.9%
    6. Materials Science00.8%
    7. Physics and Astronomy00.4%
    8. Mathematics00.3%
    1. Economics, Econometrics and Finance11.8%
    2. Psychology01.5%
    3. Social Sciences01.2%
    4. Business, Management and Accounting00.3%
    5. Decision Sciences00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.25× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.42× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 0.90× its world share, 0 worksImmunology and Micro…Neuroscience: 1.90× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 12.55× its world share, 1 worksPharmacology, Toxico…Chemistry: 1.86× its world share, 1 worksChemistryComputer Science: 0.36× its world share, 1 worksComputer ScienceEnergy: 2.19× its world share, 1 worksEnergyEngineering: 0.46× its world share, 2 worksEngineeringEnvironmental Science: 0.19× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.23× its world share, 0 worksMaterials ScienceMathematics: 0.21× its world share, 0 worksMathematicsPhysics and Astronomy: 0.18× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.57× its world share, 0 worksHealth ProfessionsMedicine: 2.74× its world share, 15 worksMedicineNursing: 2.26× its world share, 0 worksNursingBusiness, Management and Accounting: 0.07× its world share, 0 worksBusiness, Management…Decision Sciences: 0.25× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.86× its world share, 0 worksEconomics, Econometr…Psychology: 0.49× its world share, 0 worksPsychologySocial Sciences: 0.10× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 12.6×. Every wedge is a field page.

All 21 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics12.55×1 works
  2. Medicine2.74×15 works
  3. Biochemistry, Genetics and Molecular Biology2.42×4 works
  4. Nursing2.26×0 works
  5. Energy2.19×1 works
  6. Neuroscience1.90×1 works
  7. Chemistry1.86×1 works
  8. Immunology and Microbiology0.90×0 works
  9. Economics, Econometrics and Finance0.86×0 works
  10. Health Professions0.57×0 works
  11. Psychology0.49×0 works
  12. Engineering0.46×2 works
  13. Computer Science0.36×1 works
  14. Agricultural and Biological Sciences0.25×0 works
  15. Decision Sciences0.25×0 works
  16. Materials Science0.23×0 works
  17. Mathematics0.21×0 works
  18. Environmental Science0.19×0 works
  19. Physics and Astronomy0.18×0 works
  20. Social Sciences0.10×0 works
  21. Business, Management and Accounting0.07×0 works

Who are the top researchers at Torrent Pharma (India)?

Ranked on the quality score, Hiten Janardan Shah, Shitalkumar P. Zambad and Chaitanya Dutt lead among researchers whose main affiliation is Torrent Pharma (India).

  1. 1 Hiten Janardan Shah India · #4,513,616 worldwide 289 citations · 17 works
  2. 2 Shitalkumar P. Zambad India · #4,756,766 worldwide 332 citations · 20 works
  3. 3 Chaitanya Dutt India · #4,816,043 worldwide 428 citations · 20 works
  4. 4 Vijay M. Chauthaiwale India · #4,956,196 worldwide 608 citations · 26 works
  5. 5 Pankaj Kumar Jha India · #4,994,371 worldwide 224 citations · 22 works
  6. 6 Rajesh Z. Mujoriya India · #5,151,185 worldwide 109 citations · 26 works
  7. 7 Gunta Subbaiah India · #5,638,677 worldwide 987 citations · 39 works
  8. 8 Krishnaprasad Korukonda India · #5,649,570 worldwide 62 citations · 36 works
All ranked researchers at Torrent Pharma (India)

What are the most cited papers from Torrent Pharma (India)?

The most cited paper from Torrent Pharma (India) is "Recent Advances on Surface Engineering of Magnetic Iron Oxide Nanoparticles and Their Biomedical Applications" (Ajay Kumar Gupta, Rohan R Naregalkar, Vikas Deep Vaidya et al., 2007), with 716 citations. Next come "Vitamin D: The "sunshine" vitamin." (524) and "Recent advances in sample preparation techniques for effective bioanalytical methods" (366).

Most cited papers
#PaperReleasedCitations
1 Recent Advances on Surface Engineering of Magnetic Iron Oxide Nanoparticles and Their Biomedical Applications Ajay Kumar Gupta, Rohan R Naregalkar, Vikas Deep Vaidya et al. · Nanomedicine Feb 2007 716
2 Vitamin D: The "sunshine" vitamin. Rathish Nair, Arun Maseeh · PubMed Open access Apr 2012 524
3 Recent advances in sample preparation techniques for effective bioanalytical methods Prashant Laxman Kole, Gantala Venkatesh, Jignesh Kotecha et al. · Biomedical Chromatography 10 Dec 2010 366
4 1,5-Benzothiazepine, a versatile pharmacophore: A review Jitender B. Bariwal, Kuldip D. Upadhyay, Atul T. Manvar et al. · European Journal of Medicinal Chemistry 7 Jun 2008 202
5 Improved and rapid synthesis of new coumarinyl chalcone derivatives and their antiviral activity Jalpa C. Trivedi, Jitender B. Bariwal, Kuldip D. Upadhyay et al. · Tetrahedron Letters 2 Oct 2007 147
All 60 most cited papers, with filters and sorting

Which keywords describe research at Torrent Pharma (India)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Clinical Guidelines, Glycemic Control, Insulin Therapy, Cardiovascular Disease, Inflammation, Cancer Therapy, Heart Failure and Clinical Trials.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 19 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Clinical Guidelines2▲ 28×3 topics
  2. Inflammation2▲ 3.9×14 topics
  3. Cardiovascular Disease2▲ 6.4×9 topics
  4. Glycemic Control2▲ 42×2 topics
  5. Insulin Therapy2▲ 54×2 topics
  6. Cancer2▲ 4.3×7 topics
  7. Cancer Therapy2▲ 10.0×4 topics
  8. Heart Failure2▲ 12×3 topics
  9. Clinical Trials1▲ 7.8×6 topics
  10. Obesity1▲ 6.6×7 topics
  11. Neurological Disorders1▲ 8.4×5 topics
  12. Cardiovascular Outcomes1▲ 71×1 topic
  13. Cell Death1▲ 16×2 topics
  14. Glucose Control1▲ 71×1 topic
  15. Synaptic Plasticity1▲ 18×3 topics
  16. Type 2 Diabetes1▲ 18×2 topics
  17. BRCA Mutation1▲ 145×1 topic
  18. Depression1▲ 4.2×3 topics
  19. PARP Inhibitors1▲ 145×1 topic

Which research topics does Torrent Pharma (India) publish most on?

By volume in 2022-now: Diabetes Treatment and Management, PARP inhibition in cancer therapy, Pharmacology and Obesity Treatment and Treatment of Major Depression.

Diabetes Treatment and M…1Diabetes Treatment and Management: 1 fractional worksPARP inhibition in cance…1PARP inhibition in cancer therapy: 1 fractional worksPharmacology and Obesity…1Pharmacology and Obesity Treatment: 1 fractional worksTreatment of Major Depre…1Treatment of Major Depression: 1 fractional worksChronic Myeloid Leukemia Treatments: 1 fractional worksMetabolism, Diabetes, and Cancer: 1 fractional worksDiabetes Management and …1Diabetes Management and Research: 1 fractional worksAntibiotics Pharmacokinetics and Efficacy: 1 fractional worksNF-κB Signaling Pathways: 0 fractional worksBotulinum Toxin and Rela…0Botulinum Toxin and Related Neurological Disorders: 0 fractional works
Endocrinology, Diabetes and MetabolismOncologyPharmacologyHematology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 1 works
  2. 2 PARP inhibition in cancer therapy Oncology 1 works
  3. 3 Pharmacology and Obesity Treatment Pharmacology 1 works
  4. 4 Treatment of Major Depression Pharmacology 1 works
  5. 5 Chronic Myeloid Leukemia Treatments Hematology 1 works
  6. 6 Metabolism, Diabetes, and Cancer Molecular Biology 1 works
  7. 7 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 1 works
  8. 8 Antibiotics Pharmacokinetics and Efficacy Pharmacology 1 works
  9. 9 NF-κB Signaling Pathways Cancer Research 0 works
  10. 10 Botulinum Toxin and Related Neurological Disorders Neurology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available49.5%not open50.5%

World: 40% of research is openly available.

with international co-authors11.5%domestic only88.5%

World: 18% is written across borders.

How has Torrent Pharma (India)'s research output changed?

Output in 2022-2025 was 207% higher than in 2018-2021.

still counting200020052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Torrent Pharma (India) as a percentage of every work published that year, 0.000096% in 2024.

still counting0.00020%0.00040%0.00060%Torrent Pharma (India)0.00013% in 2025200020102020

Fractional works of Torrent Pharma (India) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Ahmedabad

All research institutions in Ahmedabad

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Torrent Pharma (India). Posts are plain text and can be reported.